The Learning Curve for Magnetic Resonance Imaging/Ultrasound Fusion-guided Prostate Biopsy.

[1]  D. Margolis,et al.  The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy. , 2018, European urology oncology.

[2]  D. Margolis,et al.  MRI‐Targeted or Standard Biopsy for Prostate‐Cancer Diagnosis , 2018, The New England journal of medicine.

[3]  D. Margolis,et al.  Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer , 2018, The Journal of urology.

[4]  Richard E. Fan,et al.  Prostate Magnetic Resonance Imaging Interpretation Varies Substantially Across Radiologists. , 2017, European urology focus.

[5]  P Choyke,et al.  Changes in prostate cancer detection rate of MRI-TRUS fusion vs systematic biopsy over time: evidence of a learning curve , 2017, Prostate Cancer and Prostatic Diseases.

[6]  K. Gust,et al.  From novice to expert: analyzing the learning curve for MRI-transrectal ultrasonography fusion-guided transrectal prostate biopsy , 2017, International Urology and Nephrology.

[7]  H. G. van der Poel,et al.  EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. , 2017, European urology.

[8]  M. Parmar,et al.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confi rmatory study , 2018 .

[9]  D. Margolis,et al.  Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. , 2016, The Journal of urology.

[10]  S. Tomlins,et al.  Molecular Profiling to Determine Clonality of Serial Magnetic Resonance Imaging/Ultrasound Fusion Biopsies from Men on Active Surveillance for Low-Risk Prostate Cancer , 2016, Clinical Cancer Research.

[11]  J Alfred Witjes,et al.  Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis. , 2016, European urology.

[12]  D. Margolis,et al.  Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial. , 2016, The Journal of urology.

[13]  William Hsu,et al.  Utilizing time‐driven activity‐based costing to understand the short‐ and long‐term costs of treating localized, low‐risk prostate cancer , 2015, Cancer.

[14]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[15]  J. Fütterer,et al.  Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.

[16]  M. Wirth,et al.  Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound‐fusion biopsy for the diagnosis of prostate cancer , 2015, BJU international.

[17]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[18]  P. Choyke,et al.  Prostate biopsy for the interventional radiologist. , 2014, Journal of Vascular and Interventional Radiology.

[19]  Samir S Taneja,et al.  Optimization of prostate biopsy: review of technique and complications. , 2014, The Urologic clinics of North America.

[20]  J. Kulka,et al.  The influence of expertise of the surgical pathologist to undergrading, upgrading, and understaging of prostate cancer in patients undergoing subsequent radical prostatectomy , 2014, International Urology and Nephrology.

[21]  Yair Lotan,et al.  Systematic review of complications of prostate biopsy. , 2013, European urology.

[22]  Shyam Natarajan,et al.  MRI–ultrasound fusion for guidance of targeted prostate biopsy , 2013, Current opinion in urology.

[23]  E. Şerefoğlu,et al.  How reliable is 12-core prostate biopsy procedure in the detection of prostate cancer? , 2012, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[24]  Shyam Natarajan,et al.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.

[25]  D. Hawkes,et al.  The accuracy of different biopsy strategies for the detection of clinically important prostate cancer: a computer simulation. , 2012, The Journal of urology.

[26]  U. Ferreira,et al.  Various morphometric measurements of cancer extent on needle prostatic biopsies: which is predictive of pathologic stage and biochemical recurrence following radical prostatectomy? , 2011, International Urology and Nephrology.

[27]  Xavier Leroy,et al.  Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.

[28]  S. Fosså,et al.  Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population‐based study , 2009, BJU international.

[29]  Matthew R Cooperberg,et al.  Contemporary trends in low risk prostate cancer: risk assessment and treatment. , 2007, The Journal of urology.